Exclusive Online Content
Formulation Development Success Story: Uric Acid Treatment Approved by FDA
The U.S. Food and Drug Administration recently approved a new uric acid treatment that was developed as a partnership between Metrics Contract Services and the…
Glioblastoma Treatment Hopes Turn to Combining Peptide Vaccines With Immuno-Oncology Products
The termination of Celldex’s Phase III trial assessing its peptide-based vaccine therapy, Rintega, in newly diagnosed glioblastoma patients, represents a blow to the treatment space…
Nitrogen Dioxide Sterilization: Maintains Prefilled Syringe Integrity
Noxilizer has developed an optimal sterilization process specifically for prefilled syringes and other drug-delivery devices. The low temperature NO2 sterilization process will effectively sterilize the…
Strong Life Sciences Sector Will Drive UK Pharmaceutical Market to $43 Billion
The pharmaceutical market in the UK is set to grow from $28.8 billion in 2015 to approximately $43 billion by 2020, representing a Compound Annual…
West Appoints Eric Resnick to Chief Technology Officer
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, recently announced Eric Resnick has been appointed to serve as…
ICIG to Acquire All Shares in Sandoz Industrial Products
International Chemical Investors Group (ICIG) and Novartis Group have entered into an agreement under which ICIG will acquire all of the shares in Sandoz Industrial…
How the Need for an Alternative Oral Dosage Form Delivered a Patient-Centric Drug Formulation
Dysphagia can affect many people throughout their lifetime. It also represents a challenge for oral drug manufacturers. Dysphagia not only impacts patients’ ability to take…
Unilife & Amgen Enter Strategic Collaboration for Injectable Drug Delivery Systems; Amgen to Invest up to $75 Million
Unilife Corporation recently announced a strategic collaboration with Amgen for injectable drug delivery systems. The collaboration, which includes licensing, investment, development, and supply agreement components,…
Hype Surrounding Cancer T-Cell Therapy Overlooks Safety & Cost Concerns
Although excitement surrounding recent trials of T-cell therapies and their ability to treat blood cancer has been widespread of late, there are lingering questions about…
Capsugel & Pulmatrix Enter Collaboration to Develop & Manufacture Novel Inhaled Therapeutics
Capsugel and Pulmatrix, Inc. have recently formed a collaboration to develop novel inhaled therapeutics to treat serious pulmonary diseases. The agreement provides Capsugel exclusive rights…
West's Daikyo Crystal Zenith® Cyclic Olefin Polymer Selected by Amgen
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, recently announced that global biotechnology leader Amgen Inc. has utilized…
NGS & Cloud Computing Driving Big Growth in Global Bioinformatics Markets
Next-generation sequencing (NGS) technology has fueled the genomics revolution, making it possible to sequence an entire human genome within days for a few thousand dollars.…
XBiotech Engages in Research for Heart Attack Antibody Therapy
XBiotech Inc., developer of True Human™ therapeutic antibodies, announced today the signing of a Material Transfer Agreement (MTA) with Brigham and Women’s Hospital and Massachusetts…
Merck’s Zepatier Will Threaten the Dominance of Gilead’s Harvoni in Hepatitis C Market
The introduction of Merck and Co.’s recently-approved drug Zepatier (elbasvir/grazoprevir) to the hepatitis C treatment space will shake up a market long-dominated by Gilead. The…
Infusion Pumps That Sense The Drug Flow - And Even Your Heartbeat - In It
By: Jonas Horn, Application Expert, Medical Liquid Flow Sensors Sensor technology takes infusion pumps to the next level by making failure detection reliable, even…
RNAi Therapeutics Holds Therapeutic Promise for Unmet Conditions
Ribonucleic acid interference (RNAi) mechanisms and technologies are being extensively explored in biological applications in order to silence mRNA’s encoding proteins and to develop appropriate…
Global Orphan Drug Market to Gain Almost $68 Billion by 2019; Favorable Legislation Spurring R&D
Growing competition, new technologies, improved gene therapies, and favorable legislation and incentives have led the global orphan drug market to experience a significant increase in…
Pharma Companies Must Assess Real-World Evidence to Keep Up With Shifts in the Global Market Access Landscape
As the overall costs of drugs continue to increase and pricing pressures shift the dynamics of the healthcare market, pharmaceutical companies must analyze real-world trends…
HERMES PHARMA Makes Hot-Melt Coating Available for the Pharma Industry
HERMES PHARMA, the expert in user-friendly solid oral dosage forms, recently announced the commercial implementation of hot-melt coating (HMC) in its production facility.…
Case Study of Formulating “One & Done” Daily Dosing Involving a Highly Water-Soluble API
By: Michael DeHart, PhD The Issue Metrics Contract Services was approached by a client with a commercialized drug product indicated…
